The BioIndustry Association (BIA) is pleased to announce the appointment of Will James, partner at Osborne Clarke LLP, as Vice-Chair of its Intellectual Property Advisory Committee (IPAC).
Read our statement welcoming the Chancellor’s extended venture investment tax incentives and support for employee share options, as well as the prioritisation of tax and spending decisions in areas where the UK can lead and win.
Darren Blamire, Autolus, and Diana Hernandez, Anthony Nolan, will steer BIA’s Cell and Gene Therapy Advisory Committee, driving UK leadership and patient access in this transformative field.
We're pleased to announce the appointment of Livija Deban, Chief Scientific Officer at Prokarium, as Chair of its Engineering Biology Advisory Committee (EBAC).
After 13 years at the helm of our Association, Steve Bates has tendered his resignation as CEO of the BIA. His last day at the BIA will be Friday, 26 September 2025. We all wish him well in his new role and know he will continue to champion our sector at home and abroad.
Chancellor Rachel Reeves will announce a transformative £86 billion in the Spending Review to turbo-charge our fastest growing sectors, from tech and life sciences, to advanced manufacturing and defence, as part of the government’s plan to invest in Britain’s renewal through our Modern Industrial Strategy.
BIA is pleased to announce the appointment of Lucy Foley, Chief Technology Officer at eXmoor Pharma, as Vice Chair of its Manufacturing Advisory Committee (MAC).
The Prime Minister’s announcement of a national health data research service is welcome news for the UK life science sector. We have a wealth of small innovative companies in the UK, working in an ecosystem, that are developing solutions to help us prevent, detect and treat disease better than before.
As we bid a fond farewell to Christiane Abouzeid after over 20 years of outstanding service to the BioIndustry Association, we are also thrilled to announce new leadership changes within our Policy and Public Affairs team.
